-
11.03.2025 | Frontiers in infectious diseases innovation
LA TROBE UNIVERSITY | The final event in the 2025 Industry Innovation Series, ‘Frontiers in Infectious Diseases Innovation,’ offered attendees - across industry and academia - a unique opportunity to explore pioneering advances in infectious disease solutions and collaborative opportunities.
-
10.27.2025 | Innovations offer hope in the fight against antibiotic resistance
MEDCITY NEWS | Antibiotic resistance is a growing global threat with serious health and economic consequences. Yet there is progress – from rapid PCR diagnostics and AI-driven research to new drug development and innovative funding models.
-
10.24.2025 | WHO reports 40 percent jump in antibiotic-resistant infections; BU-based nonprofit leads the fight back
THE BRINK | CARB-X, an antibiotics research accelerator, is helping bring new medicines, vaccines, and tests to clinics worldwide.
-
10.21.2025 | ‘I fear we are sitting on a time bomb.’ Scientists debate mass distribution of antibiotics in Africa
SCIENCE | Prophylactic use of azithromycin saves vulnerable children’s lives, but could trigger antibiotic resistance.
-
10.15.2025 | The National at WEF Dubai: Counting the cost of underinvesting in health
THE NATIONAL | Dubai is the stage for a World Economic Forum meeting this week that serves as a precursor to Davos in January.
-
09.26.2025 | EU and Canada advance cooperation on preparedness and response to cross-border health threats
EUROPEAN COMMISSION | From 22 to 26 September 2025, the Commission’s Health Emergency Preparedness and Response Authority (HERA) participated in a series of high-level events in Canada, underlining the importance of transatlantic cooperation in strengthening global health security and resilience.
-
09.23.2025 | La IFPMA pide implementar nuevos incentivos de ‘pull’ para fortalecer la producción de antibióticos
EL GLOBAL FARMA | La patronal de la industria farmacéutica mundial elabora un documento que describe los desafíos que socavan la I+D en antibióticos y cita las soluciones necesarias para superarlos.
-
09.15.2025 | Japan on the frontlines of a global health crisis: antimicrobial resistance
THE LOOP | Frank Tu Ngo highlights Japan’s leadership in mitigating one of today’s most urgent global health challenges, antimicrobial resistance (AMR). By capitalising on its political influence, funding, expertise, and diplomatic positioning, Japan is driving global efforts against AMR.
-
07.14.2025 | CARB-X joins Australia’s AMR network as a partner organisation
MTPCONNECT | AAMRNet, MTPConnect’s AMR initiative, is delighted to announce that the global non-profit partnership CARB-X is officially joining the Network as a partner organisation.
-
07.09.2025 | When is the superbug message going to bite?
PHARMAPHORUM | For well over a decade, scientists, health leaders, and global organisations have sounded the alarm on antimicrobial resistance – a looming crisis that could unravel a century of medical progress.
-
06.25.2025 | Antibiotico resistenza, i primi risultati della ‘lotta’ italiana
SANITA INFORMAZIONE | Al Ministero della Salute un'analisi, a sei mesi dal G7 italiano, su progressi e prospettive nella lotta all’antimicrobico-resistenza nel terzo appuntamento de “La Sanità che vorrei..."
-
06.17.2025 | New global collaboration launched to tackle antimicrobial resistance through improved diagnostics
GARDP | A new global collaboration has been launched to accelerate access to and effective use of diagnostics in the global effort to address antimicrobial resistance (AMR).
-
06.16.2025 | A stronger path forward for infection control and antimicrobial resistance: Learning from COVID-19
THE RECORD | Five years ago, the world was thrust into an unprecedented health crisis with the COVID-19 pandemic. At the time, hospitals, governments, and health organizations scrambled to respond, focusing massive attention and resources on curbing the viral threat.
-
06.13.2025 | AMR: Fixing the broken pipeline for new antibiotics
OPEN ACCESS GOVERNMENT | Melissa Gong Mitchell, the Secretariat Lead at the AMR Industry Alliance, discusses the challenges hindering the development of urgently needed new antibiotics and the sustainable solutions needed to address these issues.
-
05.13.2025 | Bridging global expertise with South Australia’s ingenuity to tackle antimicrobial resistance
MTPCONNECT | Ahead of the Australian Society for Microbiology Annual National Meeting (14-17 July) in Adelaide, we will be hosting an exclusive discussion with leading experts to uncover the myths surrounding innovation and commercialisation in the fight against antimicrobial resistance (AMR).
-
04.16.2025 | Taking the Australian AMR story to ESCMID Global Congress in Vienna
MTPCONNECT | This week around 15,000 – 20,000 delegates have converged on Austria’s capital, Vienna, for the 2025 ESCMID Global Congress - the largest conference of its kind, to focus on the latest in infectious diseases and clinical microbiology, and MTPConnect's AMR initiative, the Australian Antimicrobial Resistance Network (AAMRNet) is there.
-
04.15.2025 | Antimicrobial resistance: Q&A with CARB-X about the fight against AMR
EUROPEAN BIOTECHNOLOGY | n issue 1-25 of European Biotechnology News Magazine, we featured the ‘pandemic crossroads’ of pandemic (viral) infections and the silent pandemy of antimicrobial resistance which raises from animal farming and may help crossing the barrier of species for viruses. EBM talked to CARB-X Executive Director Kevin Outterson.
-
03.28.2025 | Innovazione e prevenzione. Così si investe sulla salute del domani
FORMICHE | Prevenzione, innovazione, ricerca: questi i temi al centro del confronto tra esperti e istituzioni sul palco del Centro studi americani.
-
02.26.2025 | CARB-X announces new round of funding for antibiotics, diagnostics
CIDRAP | CARB-X today announced a new round of funding targeting therapeutics for gram-negative bacterial infections and rapid diagnostics for typhoid fever.
-
02.07.2025 | BioInfect 2025 sees a great turnout for a day of AMR discussion
BIOINFECT | BioInfect returned to The Spine in Liverpool for the second year in a row on 5th February, with over 175 delegates, 14 exhibitors and 15 poster abstracts focusing on the issues surrounding the increasing threat of AMR and how it can be addressed.
-
01.30.2025 | Novo Nordisk Foundation granted DKK 10 billion (€1.35 billion) to benefit people and the planet in milestone year
NOVO NORDISK FOUNDATION | In 2024, on its 100th anniversary, the Novo Nordisk Foundation reached a new milestone, awarding close to DKK 10.1 billion (€1.35 billion) to support nearly 1,800 new projects aimed at improving people’s health and the sustainability of society and the planet.
-
01.27.2025 | Health experts, academics, business leaders and local students will take centre stage at antimicrobial resistance conference as BioInfect returns to Liverpool
BIONOW | Health experts, academics, business leaders and local students will take centre stage at antimicrobial resistance conference as BioInfect returns to Liverpool.
-
01.24.2025 | Muschel (Hera): “In Ue 35mila morti all’anno dovuti all’Amr, la ricerca priorità assoluta”
RIF DAY | Sono cifre da bollettino di guerra: la resistenza agli antibiotici in Europa provoca 35mila decessi all’anno.
-
01.24.2025 | Ministro Schillaci a Davos: ribadito l’impegno a contrastare la piaga della resistenza agli antibiotici
MONDOSANITA | La nostra salute sotto i riflettori in occasione del World Economic Forum di Davos, un evento annuale che riunisce statisti, leader politici, rappresentanti del mondo economico e della società civile.
-
01.22.2025 | Four opportunities to revitalize the US biomedical research enterprise
HEALTH AFFAIRS | The US biomedical research enterprise is renowned for its historical and ongoing scientific breakthroughs and advancements.
-
01.21.2025 | CARB-X funds $3.5M to Melio for rapid neonatal sepsis diagnostic
CONTAGION LIVE | CARB-X has awarded a $3.5 million grant to Melio, a biotechnology company, to develop a rapid diagnostic tool to detect neonatal sepsis.
-
01.13.2025 | How the Global AMR Innovation Fund is leading the fight against antimicrobial resistance
INNOVATION NEWS NETWORK | In a world increasingly shaped by scientific advancements, one of the most pressing challenges is antimicrobial resistance (AMR)—a growing threat to global health, economies, and future generations.
-
01.13.2025 | Collaborative innovation: Reimagining R&D partnerships to create a healthier future for everyone
WORLD ECONOMIC FORUM | Reinventing private, public and philanthropic collaboration could help develop multi-faceted solutions targeting infectious disease, mental health and the health impacts of climate change.
-
01.07.2025 | $2.6 million accelerates anti-biofilm vaccine to prevent bacterial infections
VAX BEFORE TRAVEL | CARB-X today announced it awarded Clarametyx Biosciences $2.6 million to develop an anti-biofilm vaccine.
-
01.07.2025 | CARB-X funds development of anti-biofilm vaccine
CIDRAP | CARB-X today announced an award of $2.6 million to Clarametyx Biosciences to develop an anti-biofilm vaccine.
-
01.03.2025 | Mit „sportlichem Ehrgeiz“: Gießener Forscher tüfteln an neuem Antibiotika-Wirkstoff
Gießener Allgemeine | Forscher aus Gießen arbeiten seit geraumer Zeit an einem neuen Antibiotika-Wirkstoff. Ein Blick hinter die Kulissen einer spannenden Entwicklung, die weit über die Naturwissenschaft hinausgeht.
Toggle navigation